Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.
Publication Title
Clin Transl Med
Document Type
Article
Publication Date
10-1-2024
Keywords
Animals; Male; Myeloid-Derived Suppressor Cells; Prostatic Neoplasms; Mice; Humans; Disease Models, Animal; Agaricales; Mice, Inbred C57BL; clinical trial; myeloid‐derived suppressor cells (MDSCs); nutraceutical intervention; prostate cancer; single immune cell profiling; white button mushroom.; california; santa monica; sjci
Abstract
BACKGROUND: In a previously reported Phase I trial, we observed therapy-associated declines in circulating myeloid-derived suppressor cells (MDSCs) with the administration of white button mushroom (WBM) tablets in prostate cancer (PCa) patients. These observations led us to hypothesise that WBM could mitigate PCa progression by suppressing MDSCs.
METHODS: We performed bidirectional translational research to examine the immunomodulatory effects of WBM consumption in both syngeneic murine PCa models and patients with PCa participating in an ongoing randomised Phase II trial (NCT04519879).
RESULTS: In murine models, WBM treatment significantly suppressed tumour growth with a reduction in both the number and function of MDSCs, which in turn promoted antitumour immune responses mediated by T cells and natural killer (NK) cells. In patients, after consumption of WBM tablets for 3 months, we observed a decline in circulating polymorphonuclear MDSCs (PMN-MDSCs), along with an increase in cytotoxic CD8
CONCLUSION: Our results from PCa murine models and patients provide mechanistic insights into the immunomodulatory effects of WBM and provide a scientific foundation for WBM as a nutraceutical intervention to delay or prevent PCa progression.
HIGHLIGHTS: White button mushroom (WBM) treatment resulted in a reduction in pro-tumoural MDSCs, notably polymorphonuclear MDSCs (PMN-MDSCs), along with activation of anti-tumoural T and NK cells. Human single immune cell gene expression profiling shed light on the molecular alterations induced by WBM, specifically on PMN-MDSCs. A proof-of-concept study combining WBM with PD-1 blockade in murine models revealed an additive effect on tumour regression and survival outcomes, highlighting the clinical relevance of WBM in cancer management.
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Specialty/Research Institute
Pharmacy
DOI
10.1002/ctm2.70048
- Citations
- Citation Indexes: 1
- Usage
- Abstract Views: 1
- Mentions
- Blog Mentions: 1
- News Mentions: 19